Free Trial
NASDAQ:ORKA

Oruka Therapeutics Q1 2025 Earnings Report

Oruka Therapeutics logo
$12.58 +0.39 (+3.20%)
Closing price 06/6/2025 04:00 PM Eastern
Extended Trading
$12.34 -0.23 (-1.87%)
As of 06/6/2025 07:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Oruka Therapeutics EPS Results

Actual EPS
-$0.40
Consensus EPS
-$0.57
Beat/Miss
Beat by +$0.17
One Year Ago EPS
N/A

Oruka Therapeutics Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Oruka Therapeutics Announcement Details

Quarter
Q1 2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Oruka Therapeutics' Q1 2025 earnings is scheduled for Wednesday, July 30, 2025

Earnings Documents

Oruka Therapeutics Earnings Headlines

HC Wainwright Analysts Increase Earnings Estimates for ORKA
ORKA Oruka Therapeutics, Inc.
"I'm risking my reputation on this"
Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.
See More Oruka Therapeutics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Oruka Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Oruka Therapeutics and other key companies, straight to your email.

About Oruka Therapeutics

Oruka Therapeutics (NASDAQ:ORKA) is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.

View Oruka Therapeutics Profile

More Earnings Resources from MarketBeat